Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 11, 2025
Efficacy of intensive antiemetic therapy including olanzapine in multiple myeloma patients treated with high-dose melphalan with autologous stem cell transplantationJunpei Kato, Masashi Uchida, Masayuki Ishikawa, et al.
Leukemia Research|November 11, 2008
Second myeloablative allogeneic stem cell transplantation (SCT) using cord blood for leukemia relapsed after initial allogeneic SCTTakaaki Konuma, Jun Ooi, Satoshi Takahashi, et al.
Blood|August 15, 2002
Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1Irene M Pedersen, Shinichi Kitada, Lorenzo M Leoni, et al.
Hematological Oncology|August 17, 2025
Evaluation of Delayed Initiation of Lenalidomide Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for Multiple MyelomaKoji Kawamura, Nobuhiro Tsukada, Shun-Ichi Kimura, et al.
Leukemia & Lymphoma|February 26, 2008
Early renal injury after myeloablative cord blood transplantation in adultsHiroshi Mae, Jun Ooi, Satoshi Takahashi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 18, 2015
Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute LeukemiaSeitaro Terakura, Yoshiko Atsuta, Nobuhiro Tsukada, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 1, 2026
Pre-CAR-HEMATOTOX at Leukapheresis Predicts Delayed Platelet Recovery After Idecabtagene Vicleucel in Multiple MyelomaTaku Kikuchi, Moe Nomura-Yogo, Ukyo Kondo, et al.
Blood|October 14, 2006
Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimenSatoshi Takahashi, Jun Ooi, Akira Tomonari, et al.
Transplantation and Cellular Therapy|March 6, 2026
Impact of Intensive Cyclophosphamide-containing multi-agent Bridging Therapy on Outcomes After Idecabtagene Vicleucel in Multiple MyelomaTaku Kikuchi, Ukyo Kondo, Shotaro Sugita, et al.
International Journal of Hematology|April 10, 2022
The safety and efficacy of hematopoietic stem cell mobilization using biosimilar filgrastim in related donorsRiko Tsumanuma, Eijiro Omoto, Hiroaki Kumagai, et al.
Pageof 13